Cargando…

Assessment of rosehips based on the content of their biologically active compounds

In this study, an in-depth analysis of the unique set of rosehip samples from 71 Rosa genotypes was conducted with the aim to identify the most suitable ones for applications in the food and pharmaceutical industries based on the content of biologically active compounds. In the first part of our exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhave, Apurva, Schulzova, Vera, Chmelarova, Hana, Mrnka, Libor, Hajslova, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328834/
https://www.ncbi.nlm.nih.gov/pubmed/28911653
http://dx.doi.org/10.1016/j.jfda.2016.12.019
_version_ 1784757806322155520
author Bhave, Apurva
Schulzova, Vera
Chmelarova, Hana
Mrnka, Libor
Hajslova, Jana
author_facet Bhave, Apurva
Schulzova, Vera
Chmelarova, Hana
Mrnka, Libor
Hajslova, Jana
author_sort Bhave, Apurva
collection PubMed
description In this study, an in-depth analysis of the unique set of rosehip samples from 71 Rosa genotypes was conducted with the aim to identify the most suitable ones for applications in the food and pharmaceutical industries based on the content of biologically active compounds. In the first part of our experiments, the antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl assay and the genotypes with the highest values were selected for the follow-up analysis. In the second part of experiments, the major classes of biologically active compounds in rosehips such as carotenoids, tocopherols, flavonoids, and triterpenoic acids were further quantified using liquid chromatography-based techniques. Large variation was observed among all the analyzed compounds with intraspecific variation often hiding interspecific or intersectional differences. The compounds studied herein thus do not provide a sharp tool for chemotaxonomic resolution of the genus Rosa. High intraspecific variation indicates the necessity to screen and utilize individual rose genotypes rather than representatives of the species when searching for sources of biologically active compounds. In the final stage of the study, 10 genotypes were selected for further cultivation and use, based on the highest concentrations of the analyzed biologically active compounds.
format Online
Article
Text
id pubmed-9328834
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taiwan Food and Drug Administration
record_format MEDLINE/PubMed
spelling pubmed-93288342022-08-09 Assessment of rosehips based on the content of their biologically active compounds Bhave, Apurva Schulzova, Vera Chmelarova, Hana Mrnka, Libor Hajslova, Jana J Food Drug Anal Original Article In this study, an in-depth analysis of the unique set of rosehip samples from 71 Rosa genotypes was conducted with the aim to identify the most suitable ones for applications in the food and pharmaceutical industries based on the content of biologically active compounds. In the first part of our experiments, the antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl assay and the genotypes with the highest values were selected for the follow-up analysis. In the second part of experiments, the major classes of biologically active compounds in rosehips such as carotenoids, tocopherols, flavonoids, and triterpenoic acids were further quantified using liquid chromatography-based techniques. Large variation was observed among all the analyzed compounds with intraspecific variation often hiding interspecific or intersectional differences. The compounds studied herein thus do not provide a sharp tool for chemotaxonomic resolution of the genus Rosa. High intraspecific variation indicates the necessity to screen and utilize individual rose genotypes rather than representatives of the species when searching for sources of biologically active compounds. In the final stage of the study, 10 genotypes were selected for further cultivation and use, based on the highest concentrations of the analyzed biologically active compounds. Taiwan Food and Drug Administration 2017-02-17 /pmc/articles/PMC9328834/ /pubmed/28911653 http://dx.doi.org/10.1016/j.jfda.2016.12.019 Text en © 2017 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Bhave, Apurva
Schulzova, Vera
Chmelarova, Hana
Mrnka, Libor
Hajslova, Jana
Assessment of rosehips based on the content of their biologically active compounds
title Assessment of rosehips based on the content of their biologically active compounds
title_full Assessment of rosehips based on the content of their biologically active compounds
title_fullStr Assessment of rosehips based on the content of their biologically active compounds
title_full_unstemmed Assessment of rosehips based on the content of their biologically active compounds
title_short Assessment of rosehips based on the content of their biologically active compounds
title_sort assessment of rosehips based on the content of their biologically active compounds
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328834/
https://www.ncbi.nlm.nih.gov/pubmed/28911653
http://dx.doi.org/10.1016/j.jfda.2016.12.019
work_keys_str_mv AT bhaveapurva assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds
AT schulzovavera assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds
AT chmelarovahana assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds
AT mrnkalibor assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds
AT hajslovajana assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds